-31.0%
MRNA vs RY
+106.7%
-137.7%
-93.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | RY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -2.3% | +0.1% | -0.6% |
| 7D | -12.7% | -9.3% | -3.4% | -6.5% |
| 30D | -20.7% | -8.6% | -12.0% | -15.1% |
| 3M | +46.3% | -10.0% | +56.3% | +58.2% |
| 6M | +305.2% | -0.8% | +306.0% | +292.7% |
| YTD | +561.2% | +9.7% | +551.6% | +482.8% |
| 1Y | +772.1% | +26.9% | +745.2% | +573.5% |
| 3Y | +147.0% | +127.0% | +20.0% | +19.4% |
| All | -31.0% | +106.7% | -137.7% | -59.6% |
Cumulative growth
Daily Returns
Daily percentage return beside RY.
Daily Out/Under-Performance
Portfolio return minus RY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded RY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling